Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme

被引:39
|
作者
Ahmad, Sarfaraz [1 ]
Varagic, Jasmina [1 ,2 ]
VonCannon, Jessica L. [2 ]
Groban, Leanne [2 ,3 ,4 ]
Collawn, James F. [7 ]
Dell'Italia, Louis J. [8 ]
Ferrario, Carlos M. [1 ,5 ,6 ]
机构
[1] Wake Forest Univ, Sch Med, Gen Surg, Winston Salem, NC 27109 USA
[2] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA
[3] Wake Forest Univ, Sch Med, Anesthesiol, Winston Salem, NC 27109 USA
[4] Wake Forest Univ, Sch Med, Internal Med Mol Med, Winston Salem, NC 27109 USA
[5] Wake Forest Univ, Sch Med, Internal Med Nephrol, Winston Salem, NC 27109 USA
[6] Wake Forest Univ, Sch Med, Internal Med Cardiovasc Med, Winston Salem, NC 27109 USA
[7] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA
[8] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham VA Med Ctr, Birmingham, AL 35294 USA
关键词
Rat cardiac chymase; Angiotensin-converting enzyme; Angiotensin-(1-12); Angiotensin I; Angiotensin II; Renin-angiotensin system; BLOOD-PRESSURE; II GENERATION; HIGH-GLUCOSE; SYSTEM; HEART; RATS; PROANGIOTENSIN-12; RECEPTOR; PEPTIDE; LOCALIZATION;
D O I
10.1016/j.bbrc.2016.07.100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We showed previously that rat angiotensin-(1-12) [Ang-(1-12)] is metabolized by chymase and angiotensin converting enzyme (ACE) to generate Angiotensin II (Ang II). Here, we investigated the affinity of cardiac chymase and ACE enzymes for Ang-(1-12) and Angiotensin I (Ang I) substrates. Native plasma membranes (PMs) isolated from heart and lung tissues of adult spontaneously hypertensive rats (SHR) were incubated with radiolabeled I-125-Ang-(1-12) or I-125-Ang I, in the absence or presence of a chymase or ACE inhibitor (chymostatin and lisinopril, respectively). Products were quantitated by HPLC connected to an in-line flow-through gamma detector. The rate of I-125-Ang II formation from I-125-Ang-(1-12) by chymase was significantly higher (heart: 7.0 +/- 0.6 fmol/min/mg; lung: 33 +/- 1.2 fmol/min/mg, P < 0.001) when compared to I-125-Ang I substrate (heart: 0.8 +/- 0.1 fmol/min/mg; lung: 2.1 +/- 0.1 fmol/min/mg). Substrate affinity of I-125-Ang-(1-12) for rat cardiac chymase was also confirmed using excess unlabeled Ang-(1-12) or Ang I (0-250 mu M). The rate of I-125-Ang II formation was significantly lower using unlabeled Ang-(1-12) compared to unlabeled Ang I substrate. Kinetic data showed that rat chymase has a lower K-m (64 +/- 63 mu M vs 142 +/- 17 mu M), higher V-max (132 +/- 1.3 mu M/min/mg vs 1.9 +/- 0.2 mu M/min/mg) and more than 15-fold higher catalytic efficiency (ratio of V-max/K-m) for Ang-(1-12) compared to Ang I substrate, respectively. We also investigated ACE mediated hydrolysis of I-125-Ang-(1-12) and I-125-Ang I in solubilized membrane fractions of the SHR heart and lung. Interestingly, no significant difference in I-125-Ang II formation by ACE was detected using either substrate, I-125-Ang-(1-12) or I-125-Ang I, both in the heart (1.8 +/- 0.2 fmol/min/mg and 1.8 +/- 0.3 fmol/min/mg, respectively) and in the lungs (239 +/- 25 fmol/min/mg and 248 +/- 34 fmol/min/mg, respectively). Compared to chymase, ACE-mediated Ang-(1-12) metabolism in the heart was several fold lower. Overall our findings suggest that Ang-(1-12), not Ang I, is the better substrate for Ang II formation by chymase in adult rats. In addition, this confirms our previous observation that chymase (rather than ACE) is the main hydrolyzing enzyme responsible for Ang II generation from Ang-(1-12) in the adult rat heart. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 50 条
  • [41] Bilateral nephrectomy augments the cardiac content of angiotensin-(1-12) and angiotensin I in Wistar Kyoto rats
    Ferrario, Carlos M.
    Varagic, Jasmina
    Chappell, Mark C.
    Trask, Aaron J.
    Nagata, Sayaka
    Kato, Johji
    HYPERTENSION, 2008, 52 (04) : E126 - E126
  • [42] Angiotensin in cardiac surgery: efficacy in patients on angiotensin converting enzyme inhibitors
    Bennett, SR
    McKeown, J
    Drew, P
    Griffin, S
    EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (05) : 587 - 592
  • [43] Effect of angiotensin II type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters
    Shimizu, M
    Tanaka, R
    Uchida, M
    Orito, K
    Shimamura, S
    Yamane, Y
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2006, 68 (03): : 227 - 233
  • [44] Differential effects of ACE and chymase in the metabolism of exogenous angiotensin-(1-12) in Wistar-Kyoto rats
    Moniwa, Norihito
    Varagic, Jasmina
    Ahmad, Sarfaraz
    Ferrario, Carlos M.
    FASEB JOURNAL, 2012, 26
  • [45] Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system
    Santos, Robson A. S.
    Ferreira, Anderson J.
    Verano-Braga, Thiago
    Bader, Michael
    JOURNAL OF ENDOCRINOLOGY, 2013, 216 (02) : R1 - R17
  • [46] Uptake and Metabolism of the Novel Peptide Angiotensin-(1-12) by Neonatal Cardiac Myocytes
    Ahmad, Sarfaraz
    Varagic, Jasmina
    Westwood, Brian M.
    Chappell, Mark C.
    Ferrario, Carlos M.
    PLOS ONE, 2011, 6 (01):
  • [47] Release of angiotensin-(1-7) from the rat hindlimb - Influence of angiotensin-converting enzyme inhibition
    Chappell, MC
    Gomez, MN
    Pirro, NT
    Ferrario, CM
    HYPERTENSION, 2000, 35 (01) : 348 - 352
  • [48] Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle
    De Mello, W. C.
    Dell'Itallia, L. J.
    Varagic, J.
    Ferrario, C. M.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 422 (1-2) : 31 - 40
  • [49] Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions
    Ohishi, M
    Ueda, M
    Rakugi, H
    Naruko, T
    Kojima, A
    Okamura, A
    Higaki, J
    Ogihara, T
    JOURNAL OF HYPERTENSION, 1999, 17 (04) : 547 - 553
  • [50] Angiotensin-(1-7), Angiotensin-Converting Enzyme 2 and Mas Receptor in Rat Polycystic Ovaries
    Pereira, Virginia M.
    Reis, Fernando M.
    Casalechi, Maira
    Reis, Adelina M.
    PROTEIN AND PEPTIDE LETTERS, 2021, 28 (03): : 249 - 254